Keep informed about the latest topics in global health.
#VaccinesWork
FOCUS AREAS African Vaccine Manufacturing Accelerator (AVMA) Zero-Dose Child Gavi Secretariat and leadership Progress report Partners Our Board
CAREERS Current vacancies Internship programme RFPs and consulting
Contact us ISO certification Phishing and fraud
SUPPORTED COUNTRIESDetailed information on each Gavi-eligible countryExplore our Country Hub
FOR COUNTRIES
Apply for support
Gavi 5.0 Ceilings by country and support type
OUR RESULTS
Evaluation studies
Facts and figures
Progress reports
COVID-19
The Global Vaccine Impact Conference explained
Read article
KEY AREAS
Donor profiles
Matching Fund
Pneumococcal AMC
FEATURED STORY
Everything you need to know about Gavi's incoming CEO, Dr Sania Nishtar
KEY PUBLICATION
The 2023 Mid-Term Review Report
PROGRESS REPORT
Access all of the press releases and statements related to the work of the Vaccine Alliance
12 November 2015
Unprecedented number of children protected against pneumonia with Gavi support
10 November 2015
Scientists mark 'stunning success' of vaccine in virtually ridding Africa of meningitis A
23 October 2015
Gavi and Global Fund statement on malaria vaccine recommendations
6 October 2015
New commitment from the Republic of Korea to Gavi will support childhood immunisation in the world's poorest countries
30 September 2015
New polio vaccine introduced to accelerate polio eradication in Afghanistan
28 September 2015
Gavi welcomes global goals and renews call for immunisation indicator
21 September 2015
Ngozi Okonjo-Iweala appointed Chair-elect of Gavi Board
9 September 2015
China seals commitment to support immunisation in developing countries
20 August 2015
More than four million children per year in Pakistan to benefit from new injectable polio vaccine
18 August 2015
People in Cameroon to be protected against cholera with Gavi-supported vaccine
12 August 2015
More than 200,000 Papua New Guinea children to be protected with the new polio and measles-rubella vaccines
31 July 2015
Encouraging trial results offer significant hope for rapid availability of Ebola vaccine to end current outbreak